NICE News September 2015

New guidance and standards Offer personalised care to support those who need help to live at home  Home care visits to elderly people should last for at least half an hour and focus on what they can or would like to do rather than on what they can't do, says NICE. NICE's first guideline for the social care sector is of relevance to local authorities, CCGs, and others who commission home care services.

Read more

Antibiotics not effective for rare heart infection  Antibiotics should not be prescribed to prevent infective endocarditis - a potentially fatal heart infection, NICE has reaffirmed. This follows research published in The Lancetlast year which suggested that rates of infective endocarditis had increased in England after NICE advised against giving antibiotics to prevent the infection.

Read more

News NICE joins project to make development of new treatments more efficient NICE is a partner of a new public-private project which aims to identify activities that can make the development and regulation of medicines more efficient. Called the Accelerated Development of Appropriate Patient Therapies (ADAPT SMART), the project is a collaborated between 32 international partners that includes regulators, patients, academia, and industry representatives.

Read more

NICE to sponsor new NHS vanguards NICE is sponsoring four 'vanguards' - groups of NHS and local government organisations that have been designated to pilot the new models of care described in the NHS Five Year Forward View.

Read more

Features Vanguards: piloting new models of care for the NHS We take a closer look at the work of the vanguards, and an organisation in West Wakefield in particular. The vanguards are piloting new models of care to help set a blueprint for a revamped NHS.

Read more

Into practice Online learning tool for bladder cancer  NICE has launched a new online learning tool to support the implementation of the guideline on bladder cancer. The tool uses interactive activities and case studies to support clinicians in diagnosing, staging and treating non-muscle-invasive and muscle-invasive bladder cancer.

Read more

Get involved  NICE is developing a quality standard on gastro-oesophageal reflux disease in children and young people. Have your say on the draft quality standard which consists of eight statements designed to improve care.

Read more

Comment on the draft guideline on the diagnosis and management of myeloma in adults. Recommendations cover advice on communication and support, laboratory investigations, imaging investigations, as well as managing newly diagnosed myeloma and the complications of myeloma.

Read more

EXCLUSIVE discount for NICE Annual Conference 2015 We are offering NICE News subscribers a 30% discount for the NICE Annual Conference next month. The NICE Annual Conference 2015 is a unique opportunity for those working across health, social care, and public health to come together and share best practice in providing high quality care. Join more than 900 professionals to learn more about NICE's work and how NICE can support you in your role. Use NICENEWS30 to get your 30% discount online now.

Register now

Public Q&A with NICE’s Chair and Chief Executive – 18 November 2015, London Have you got a burning question you want to ask NICE? Do you want to find out more about how using NICE guidance and quality standards can help you deliver the best care? Then book your place today to attend NICE Question Time and Public Board Meeting, on Wednesday 18 November 2015 at St George's Hospital, London.

Register now

Coming soon Look out for NICE’s upcoming guideline on preterm birth and labour expected in November 2015.

Read more

Guidance, standards and advice      Guidance Coeliac disease (update) Prophylaxis against infective endocarditis (update) Home care UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia Virtual Touch Quantification to diagnose and monitor liver fibrosis Technology appraisals  Polycythaemia vera - ruxolitinib (after hydroxycarbamide) - Terminated appraisal TA355 AF (non-valvular, stroke & embolism prev) - edoxaban tosylate Quality Standards Cardiovascular risk assessment and lipid modification Secondary prevention of myocardial infarction and cardiac rehabilitation Medtech Innovation Briefings  i-STAT Chem8+ and GC4+ cartridges for point-of-care testing in the emergency department Thermoguard XP intravascular temperature management system Evidence Summaries  Topical timolol for infantile haemangioma